Home / Posts Tagged "Pfizer"

  Abrocitinib is the first-of-its-kind oral advanced systemic treatment for adults with moderate-to-severe atopic dermatitis, to be made available in India. Abrocitinib provides rapid itch relief, sustained control of the disease and improved quality of life. Pfizer has received marketing authorization for abrocitinib in adults

READ MORE

Health and Wellness NCD screening kiosks set up in 4 hospitals Virtual Patient Helpdesk engages with over 50,000 patients Over 5000 General Practitioners and ASHA workers trained in early detection and palliative care services Patient tracking and referral app launched   Pfizer today announced that its

READ MORE

Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp). The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed

READ MORE

On Monday, Moderna Inc (MRNA.O) said its COVID-19 vaccine which generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and

READ MORE

Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Sunday, predicting a timetable that could see many kids getting fully vaccinated before the end of

READ MORE

On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N) shots, and said Americans can choose a different shot from their original inoculation as a booster. CDC director

READ MORE

Asserting that India is on track to vaccinate its entire adult population by December, top officials sources on Monday said a blueprint is in place to ensure a total supply of 187.2 crore doses by the year-end that would be enough for the country’s 94

READ MORE

The World Health Organisation (WHO) said on Tuesday that it has approved China’s second COVID-19 vaccine ‘Sinovac’ for emergency use listing. “WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for

READ MORE

Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday. The ministry said Government of India, through the National Expert Group on Vaccine Administration for COVID-19

READ MORE